Vivo Cannabis Reduces Outstanding Debentures From $27.1 Million To $6.6 Million

Vivo Cannabis (TSX: VIVO) has significant reduced its outstanding debt obligations through amendments to certain convertible debentures that remain on its books. The company has seen its previously outstanding $27.1 million convertible debentures reduced down to $6.6 million following negotiations with the debtholders.

The repaid debentures are that of the debentures issued in February 2018, bearing interest at a rate of 6.0% per annum. An original amount of $34.5 million debentures were issued, however in April and May of 2020 the company repurchased $10.0 million, and $0.88 million worth of units at a 7.0% discount to market value. This left $23.6 million in principal value of debt remaining as of June 30, 2020.

The amended agreement has seen Vivo repay 44.32% of the outstanding debentures, amount to a total value of $10.5 million, which will occur on a pro-rata basis, at no discount to the value. A further 27.84% of the debt, amounting to $6.6 million, will then be converted on a pro-rata basis, through the issuance of units of the company.

Units issued under this arrangement will see an issuance price of $0.2004, and contain one common share and one half of a purchase warrant exercisable at $0.2672 until February 15, 2022. The conversion price is a far cry from the original $4.00 per share set forth at the time of the debt issuance – just 5% of the original figure. 32,813,413 units of the company are expected to be issued as a result.

The remaining $6.6 million in debentures will see their maturity extended from February 28, 2021, to September 15, 2022, while the conversion price falls to $0.2672.

Currently outstanding 7% debentures, issued in December 2017, meanwhile will see the outstanding $3.5 million in principal repaid in December 2020.

Vivo Cannabis last traded at $0.20 on the TSX.


Information for this briefing was found via Sedar and Vivo Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q3 Earnings: Another RECORD Quarter!

Barrick Q3 Earnings: Juicing Shareholder Returns Amid Declining Production

Wheaton Q3 Earnings: Cash Operating Margins Skyrocket

Recommended

Altamira Gold Encounters Second Porphyry Body, Hitting 3.5 g/t Gold Over 8.0 Metres

Canadian Copper Set To Submit Environmental Impact Assessment In H1 2026 For Murray Brook

Related News

The Public Partners of Westleaf

Westleaf Inc (TSXV: WL) is a $300 million company in which we can almost guarantee...

Monday, January 28, 2019, 02:00:06 PM

Public Cannabis Companies Have Already Received More Than $25 Million in Federal Wage Subsidies

In response to the spread of COVID-19, the Canadian Federal Government introduced several programs to...

Saturday, November 14, 2020, 10:00:00 AM

MediPharm Labs, Vivo Cannabis Slump After Announcing All-Stock Deal

MediPharm Labs (TSX: LABS) announced on Thursday an all-equity deal to acquire VIVO Cannabis (TSX:...

Sunday, December 25, 2022, 01:35:00 PM

Canopy Growth’s Bruce Linton Finds Himself in a Catch-22

Canopy Growth Corp’s (TSX: WEED) (NYSE: CGC) Bruce Linton came under fire yesterday across social...

Friday, June 28, 2019, 09:22:46 AM

Vivo Cannabis Reduces Headcount 18%, To Sell Off Non-Core Assets

Vivo Cannabis (TSX: VIVO) is the latest cannabis issuer to “streamline operations” via significant layoffs...

Tuesday, October 20, 2020, 08:36:29 AM